Health Canada approves Moderna's mRNA RSV vaccine, company says

Health Canada approves Moderna’s mRNA RSV vaccine, company says

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older.

Canada approves Moderna's RSV vaccine for those age 60 and older, company says

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making it the country's first authorized mRNA-based shot for the condition.

Health Canada approves Moderna's mRNA RSV vaccine, company says

Breaking News, Sports, Manitoba, Canada

Moderna’s mRNA RSV Vaccine Receives Health Canada Approval For Adults Aged 60 Years And Over - Life Sciences British Columbia

mRESVIA is Moderna’s second approved product in Canada and is the first mRNA vaccine for RSV and the only one in single-dose pre-filled syringes Canada is the fourth jurisdiction to approve mRESVIA following approvals in the U.S., Europe, and Qatar CAMBRIDGE, MA – Moderna, Inc. (Nasdaq:MRNA) announced Health Canada has approved mRESVIA (Respiratory Syncy-al Virus mRNA vaccine) for active immunization for the prevention of lower respiratory trac…

Health Canada approves Moderna’s mRNA RSV vaccine, company says – 105.9 The Region

TORONTO — Health Canada has approved Moderna’s mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older — but it won’t be available until next year, the company said on Friday. In a news release, Moderna said it expects the RSV vaccine — called mRESVIA — to be available in early 2025. There are two other vaccines already available in Canada to protect seniors against severe illness caused by RSV: Arexvy, manufactu…